US CDC 2019-nCoV ValuPanel Reagents by LGC, Biosearch Technologies

With a proven track record supporting public health crises and the expertise to rapidly scale high-quality oligonucleotide production to meet growing demand for testing reagents, LGC, Biosearch Technologies is prepared to support testing to help slow the spread of COVID-19.

Key features

• Flexibility: Probes and primers are delivered in individual tubes, available in different sizes to support anywhere from 1,000 to 100,000 reactions to meet the requirements of various protocols and offer the ability to scale
• Original source, reliable supply: Both BHQ™ and BlackBerry™ (BBQ-650) quenchers referenced in the Charité and US CDC protocols are Biosearch Technologies’ proprietary technology.  Berry & Associates, Inventor of BBQ-650 technology is now part of the Biosearch Technologies brand.
• Quality manufacture: All probes are HPLC purified. Oligos are manufactured and shipped from a facility entirely separate from positive control production. 

Product info

This panel consists of FAM-BHQ probes for use in real-time RT PCR to discriminate SARS-CoV-2 viral strains. This ValuPanel contains probes and primers comprising the following genetic signatures:

• N
• RNase P

Oligonucleotide sequences were designed by US Centers for Disease Control and Prevention. All probes are labeled with FAM and BHQ dyes, and are HPLC purified.